|
EP2732287A2
|
|
Methods of prognosing chronic lymphocytic leukemia
|
|
CA2823191A1
|
|
Apoe peptide dimers and uses thereof
|
|
CN102137680A
|
|
Methods of treating cancer with APOE peptides
|
|
WO2009018477A2
|
|
Methods of inhibiting calcineurin with apoe analogs
|
|
US2009131315A1
|
|
Treatment of subarachnoid hemorrhage with Apo E analogs
|
|
CA2672638A1
|
|
Methods for modulating set and uses thereof
|
|
EP2801366A2
|
|
Improved apo E analogs and methods for their use
|
|
AU2003273540A8
|
|
Assays for measuring matrix metalloproteinase activities
|
|
US7205280B2
|
|
Methods of suppressing microglial activation
|
|
US6593512B1
|
|
Transgenic mouse expressing human tau gene
|
